Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8448

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,448 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
PHM Pharma Mar	€98.40	2.6%	198.7%	€1.7b	€91.00	PE2753.7x	E45.4%	0.7%	Pharmaceuticals & Biotech
FWRY Fawry for Banking Technology and Electronic PaymentsE	ج.م8.31	1.3%	45.5%	ج.م28.3b	ج.م12.45	PE22.9x	E27.4%	n/a	Diversified Financials
AFISH Arctic Fish Holding	NOK 61.00	-8.3%	5.2%	NOK 1.9b	NOK 81.00	PE63.8x	E55.2%	n/a	Food, Beverage & Tobacco
MBTN Meyer Burger Technology	CHF 1.78	-6.3%	-97.4%	CHF 54.9m	CHF 6.03	PS0.6x	E109.3%	n/a	Semiconductors
AGP Altea Green Power	€6.52	26.1%	-18.9%	€118.9m	€12.40	PE17.6x	E23.3%	n/a	Capital Goods
CADLR Cadeler	NOK 52.00	-4.2%	18.2%	NOK 18.2b	NOK 81.13	PE171.7x	E70.7%	n/a	Capital Goods
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.77	12.5%	25.2%	ج.م5.7b	ج.م5.18	PE21.3x	E30.7%	1.8%	Pharmaceuticals & Biotech
GUINNESS Guinness Nigeria	₦74.00	-3.9%	45.1%	₦162.1b	₦74.24	PS0.4x	E119.5%	0%	Food, Beverage & Tobacco
RHM Rheinmetall	€889.60	17.5%	121.5%	€38.6b	€862.93	PE56.4x	E30.5%	0.6%	Capital Goods
PRL Propel Holdings	CA$33.29	-8.5%	97.9%	CA$1.3b	CA$45.45	PE21.1x	E38.7%	1.8%	Diversified Financials
ACE Ascelia Pharma	SEK 3.29	7.0%	-55.7%	SEK 316.2m	SEK 7.68	PB4x	E66.9%	n/a	Pharmaceuticals & Biotech
ELABS Elliptic Laboratories	NOK 9.63	1.6%	-29.4%	NOK 1.0b	NOK 19.00	PS10.8x	E121.1%	n/a	Software
ICOP I.CO.P.. Società Benefit	€8.26	0%	n/a	€228.3m	€9.80	PE45.2x	E49.2%	n/a	Capital Goods
XSPRAY Xspray Pharma	SEK 31.45	-9.2%	-22.9%	SEK 1.2b	SEK 55.50	PB1.9x	E104.9%	n/a	Pharmaceuticals & Biotech
ARES Ares Management	US$179.69	-2.5%	34.1%	US$58.5b	US$198.57	PE82.3x	E41.4%	2.5%	Diversified Financials
ALNY Alnylam Pharmaceuticals	US$251.00	-5.2%	54.2%	US$32.4b	US$301.27	PS14.5x	E59.1%	n/a	Pharmaceuticals & Biotech
RCEL AVITA Medical	US$9.95	13.3%	-41.5%	US$269.4m	US$16.28	PS4.1x	E55.3%	n/a	Pharmaceuticals & Biotech
AXSM Axsome Therapeutics	US$129.10	-2.0%	60.4%	US$6.2b	US$166.12	PS16.3x	E58.9%	n/a	Pharmaceuticals & Biotech
GAU Galiano Gold	CA$1.89	0.5%	52.4%	CA$470.5m	CA$3.08	PS2.1x	E65.4%	n/a	Materials
TEND3 Construtora Tenda	R$16.48	6.7%	45.8%	R$2.0b	R$18.95	PE30.9x	E74.3%	1.0%	Consumer Durables
ALKT Alkami Technology	US$31.83	-2.9%	25.3%	US$3.2b	US$45.10	PS10.1x	E102.7%	n/a	Software
TGTX TG Therapeutics	US$30.94	0.7%	130.2%	US$4.5b	US$40.33	PS16.8x	E45.2%	n/a	Pharmaceuticals & Biotech
LAVV3 Lavvi Empreendimentos Imobiliários	R$8.80	2.0%	11.4%	R$1.7b	R$12.47	PE5.5x	E22.8%	3.2%	Real Estate Management and Development
TVTX Travere Therapeutics	US$23.58	-0.6%	200.0%	US$2.0b	US$32.27	PS10.1x	E61.7%	n/a	Pharmaceuticals & Biotech

Page 1 of 352